Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
Abstract The effectiveness of Coronavirus disease 2019 (COVID-19) vaccines against the long-term COVID-19 symptoms expressed by a substantial proportion of patients is not well understood. We determined whether vaccination with the BNT162b2 mRNA vaccine was associated with incidence of reporting lon...
Main Authors: | Paul Kuodi, Yanay Gorelik, Hiba Zayyad, Ofir Wertheim, Karine Beiruti Wiegler, Kamal Abu Jabal, Amiel A. Dror, Saleh Nazzal, Daniel Glikman, Michael Edelstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-022-00526-5 |
Similar Items
-
Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel
by: Paul Kuodi, et al.
Published: (2023-09-01) -
Changes in Quality of Life Following SARS-CoV-2 Infection Among Jewish and Arab Populations in Israel: A Cross-Sectional Study
by: Jelte Elsinga, et al.
Published: (2023-06-01) -
Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022
by: Michael Edelstein, et al.
Published: (2023-10-01) -
Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021
by: Yanay Gorelik, et al.
Published: (2022-01-01) -
Characterization of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis
by: Paul Kuodi, et al.
Published: (2023-09-01)